Ten Years at the Koch Institute
Friday, June 17, 2022, 8:00 a.m. – 5:00 p.m. EDT
Kresge Auditorium (map) and online
Register to attend in person or virtually on Eventbrite
Join us for the 20th Annual Cancer Research Symposium hosted by MIT's Koch Institute for Integrative Cancer Research.
Agenda
8:00–9:00 A.M.
Registration
9:00–9:15 A.M.
Opening Remarks
Richard Hynes
Koch Institute for Integrative Cancer Research at MIT
9:15–10:35 A.M.Session I: The Koch Institute on the National Cancer Stage
Session Chair: Tyler Jacks
Koch Institute for Integrative Cancer Research at MIT
Ending cancer as we know it: forecasting the future of U.S. cancer mortality
Ned Sharpless
Former Director of the National Cancer Institute (NCI)
A presidential perspective
Francis Collins
Science Advisor to the President and Co-Chair of the President’s Council of Advisors on Science and Technology (PCAST)
Thinking differently: making the improbable possible in a new era
Matthew Vander Heiden
Director of the Koch Institute for Integrative Cancer Research at MIT
10:35–11:00 A.M.
Break
11:00 A.M.–1:05 P.M.
Session II: Convergent Science and Future Science
Session Chair: Paula Hammond
Koch Institute for Integrative Cancer Research at MIT
11:00 A.M.–12:05 P.M.
Panel Discussion: Convergent Science
Sangeeta Bhatia
John J. and Dorothy Wilson Professor of Engineering; Director, Marble Center for Cancer Nanomedicine; Investigator, Howard Hughes Medical Institute
Paula Hammond
Institute Professor and Head of the Department of Chemical Engineering, MIT; Member, Koch Institute
Susan Hockfield
MIT President Emerita and Professor of Neuroscience; Member, Koch Institute
Aviv Regev
Head, Genentech Research and Early Development, Roche
Phillip Sharp
Institute Professor and Professor of Biology, MIT; Member, Koch Institute
12:05–1:05 P.M.
Presenters
Inroads to MYC
Angela Koehler
Associate Professor, MIT Department of Biological Engineering; Interim Associate Director of the Koch Institute
Deconstructing cancer using precision functional genomics
Francisco J. Sánchez-Rivera
Assistant Professor, MIT Department of Biology; Member, Koch Institute
Cancer nanomedicine at the interface
Joelle Straehla
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator, Koch Institute; Instructor, Pediatric Hematology/Oncology, DFCI/BCH
Mechanisms of gene regulation by chromatin adaptor proteins
Yadira Soto-Feliciano
Assistant Professor, MIT Department of Biology; Member, Koch Institute
1:05–2:30 P.M.
Lunch Break
2:30–4:30 P.M.
Session III: Where are they now? Welcoming back our alumni
Session Chair: Jacqueline Lees
Koch Institute for Integrative Cancer Research at MIT
Transforming the oral route: new approaches for delivering macromolecules, creating ultra-long acting therapies and more
Giovanni Traverso
Karl Van Tassel (1925) Career Development Professor, MIT Department of Mechanical Engineering; Assistant Professor, Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School
Spatially-resolved assessment of metabolism
Shawn Davidson
Associate Research Scholar and Lecturer, Lewis-Sigler Institute for Integrative Genomics, Princeton University
Lab-in-a-tumor microdevices for multiple drug measurements in cancer patients
Oliver Jonas
Assistant Professor, Harvard Medical School; Department of Radiology, Brigham & Women’s Hospital; Faculty, Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute
Cell atlases as roadmaps to understand and treat cancer
Aviv Regev
Head, Genentech Research and Early Development, Roche
4:30 P.M.
Closing Remarks
Matthew Vander Heiden
Director, Koch Institute for Integrative Cancer Research at MIT
Thank you to our sponsors:
Platinum
Silver
Bronze
With additional support provided by:
